Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP.

× No keyword cloud information.

8 in total

Review 1. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Authors: Mazie Tsang; Sameer A Parikh
Journal: Curr Hematol Malig Rep Date: 2017-02 Impact factor: 3.952

2. Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.

Authors: Bin Zhang; Ling Li; Yinwei Ho; Min Li; Guido Marcucci; Wei Tong; Ravi Bhatia
Journal: J Clin Invest Date: 2016-02-15 Impact factor: 14.808

Review 3. Chronic lymphocytic leukemia and autoimmunity: a systematic review.

Authors: Kate Hodgson; Gerardo Ferrer; Emili Montserrat; Carol Moreno
Journal: Haematologica Date: 2011-01-17 Impact factor: 9.941

4. Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.

Authors: Cristina Santoro; Paola Volpicelli; Erminia Baldacci; Grazia Ferrara; Alice Di Rocco; Antonietta Ferretti; Marika Porrazzo; Maria Gabriella Mazzucconi
Journal: Clin Case Rep Date: 2017-07-13

5. Successful Long-Term Use of Eltrombopag in a Patient with Refractory Severe Thrombocytopenia Associated with Chronic Lymphocytic Leukemia That Allowed Oral Anticoagulant Treatment for Severe Cardiomyopathy.

Authors: Juárez Salcedo Luis Miguel; Gil-Fernández Juan José
Journal: Case Rep Hematol Date: 2017-04-02

Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP.

Review 1. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

2. Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.

Review 3. Chronic lymphocytic leukemia and autoimmunity: a systematic review.

4. Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.

5. Successful Long-Term Use of Eltrombopag in a Patient with Refractory Severe Thrombocytopenia Associated with Chronic Lymphocytic Leukemia That Allowed Oral Anticoagulant Treatment for Severe Cardiomyopathy.

Review 6. Autoimmune cytopenias in chronic lymphocytic leukemia.

7. The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemia.

Review 8. Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.